Insider · CIK 0001796545
Julie Larson-Green
Files at HCAT (Health Catalyst, Inc.). First filing Dec 9, 2025, latest Dec 9, 2025.
Julie Larson-Green files SEC Form 4 as director at HCAT (Health Catalyst, Inc.). Since Dec 9, 2025, Julie Larson-Green has reported 0 open-market buys worth $0 and 1 open-market sell worth $128k, the latest filed on Dec 9, 2025.
A track record needs three past buys with six months of prices behind them; Julie Larson-Green has 0, so none is measured yet.
The newest scored trade: sold $128k of HCAT on Dec 4, 2025, filed Dec 9, 2025, scored 44 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $128k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HCAT: Health Catalyst, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | Health Catalyst, Inc. | $128k 47,997 shares | -39% | +33% from low-68% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 4, 2025 | HCAT HEALTH CATALYST INC | 47,997 0.07% of outstanding | $128k | Dec 4, 2025 | none |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +9,766 | $0.00 | $0 | 185,101 | 40 d ago |
| Jun 1, 2026 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +12,710 | $0.00 | $0 | 94,644 | Jun 3, 2026 |
| Mar 1, 2026 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +8,361 | $0.00 | $0 | 81,934 | Mar 5, 2026 |
| Dec 4, 2025 | HCAT Health Catalyst, Inc. | SOpen-market sale Common Stock | -47,997 | $2.67 | $128k | 73,573 | Dec 9, 2025 |
| Dec 1, 2025 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +5,731 | $0.00 | $0 | 121,570 | Dec 3, 2025 |
| Sep 1, 2025 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +4,588 | $0.00 | $0 | 115,839 | Sep 5, 2025 |
| Jul 9, 2025 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +36,231 | $0.00 | $0 | 111,251 | Jul 10, 2025 |
| Jun 1, 2025 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +3,766 | $0.00 | $0 | 75,020 | Jun 3, 2025 |
| Mar 1, 2025 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +2,450 | $0.00 | $0 | 71,254 | Mar 4, 2025 |
| Dec 1, 2024 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +1,616 | $0.00 | $0 | 68,804 | Dec 3, 2024 |
Questions about Julie Larson-Green
Answered from the filings on this page, as of the latest one.
Is Julie Larson-Green buying or selling?
In the last 12 months Julie Larson-Green reported 0 open-market buys worth $0 and 1 open-market sell worth $128k on SEC Form 4; the latest was sold $128k of HCAT on Dec 4, 2025. Grants, option exercises and tax withholding are not counted.
How did Julie Larson-Green's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Julie Larson-Green has 0.
Where does Julie Larson-Green file Form 4?
Julie Larson-Green has filed Form 4 at HCAT (Health Catalyst, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.